Literature DB >> 22064355

SF3B1 mutations in myelodysplastic syndromes: clinical associations and prognostic implications.

F Damm, F Thol, O Kosmider, S Kade, P Löffeld, F Dreyfus, A Stamatoullas-Bastard, A Tanguy-Schmidt, O Beyne-Rauzy, S de Botton, A Guerci-Bresler, G Göhring, B Schlegelberger, A Ganser, O A Bernard, M Fontenay, M Heuser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22064355     DOI： 10.1038/leu.2011.321

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  45 in total

1.  Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes.

Authors:  David P Steensma; Rafael Bejar; Siddhartha Jaiswal; R Coleman Lindsley; Mikkael A Sekeres; Robert P Hasserjian; Benjamin L Ebert
Journal:  Blood       Date:  2015-04-30       Impact factor: 22.113

2.  High frequencies of SF3B1 and JAK2 mutations in refractory anemia with ring sideroblasts associated with marked thrombocytosis strengthen the assignment to the category of myelodysplastic/myeloproliferative neoplasms.

Authors:  Sabine Jeromin; Torsten Haferlach; Vera Grossmann; Tamara Alpermann; Andreas Kowarsch; Claudia Haferlach; Wolfgang Kern; Susanne Schnittger
Journal:  Haematologica       Date:  2012-08-28       Impact factor: 9.941

Review 3.  Molecular pathophysiology of myelodysplastic syndromes.

Authors:  R Coleman Lindsley; Benjamin L Ebert
Journal:  Annu Rev Pathol       Date:  2012-08-28       Impact factor: 23.472

4.  Methylation of promoters of microRNAs and their host genes in myelodysplastic syndromes.

Authors:  Begum Erdogan; Amma Bosompem; Dunfa Peng; Leng Han; Emily Smith; Mija E Kennedy; Catherine E Alford; Huiyun Wu; Zhongming Zhao; Claudio A Mosse; Wael El-Rifai; Annette S Kim
Journal:  Leuk Lymphoma       Date:  2013-05-15

Review 5.  Genomic tools in acute myeloid leukemia: From the bench to the bedside.

Authors:  Brian S White; John F DiPersio
Journal:  Cancer       Date:  2014-01-28       Impact factor: 6.860

Review 6.  Splicing factor mutations in myelodysplasia.

Authors:  Seishi Ogawa
Journal:  Int J Hematol       Date:  2012-10-05       Impact factor: 2.490

7.  SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromes.

Authors:  Valeria Visconte; Heesun J Rogers; Jarnail Singh; John Barnard; Manoj Bupathi; Fabiola Traina; James McMahon; Hideki Makishima; Hadrian Szpurka; Anna Jankowska; Andres Jerez; Mikkael A Sekeres; Yogen Saunthararajah; Anjali S Advani; Edward Copelan; Haruhiko Koseki; Kyoichi Isono; Richard A Padgett; Sami Osman; Kazunori Koide; Christine O'Keefe; Jaroslaw P Maciejewski; Ramon V Tiu
Journal:  Blood       Date:  2012-07-23       Impact factor: 22.113

Review 8.  Splicing factor gene mutations in hematologic malignancies.

Authors:  Borja Saez; Matthew J Walter; Timothy A Graubert
Journal:  Blood       Date:  2016-12-09       Impact factor: 22.113

9.  The transporter ABCB7 is a mediator of the phenotype of acquired refractory anemia with ring sideroblasts.

Authors:  Maryam Nikpour; Christian Scharenberg; Anquan Liu; Simona Conte; Mohsen Karimi; Teresa Mortera-Blanco; Valentina Giai; Marta Fernandez-Mercado; Elli Papaemmanuil; Kari Högstrand; Monika Jansson; Inger Vedin; James Stephen Wainscoat; Peter Campbell; Mario Cazzola; Jacqueline Boultwood; Alf Grandien; Eva Hellström-Lindberg
Journal:  Leukemia       Date:  2012-10-16       Impact factor: 11.528

Review 10.  The development and application of small molecule modulators of SF3b as therapeutic agents for cancer.

Authors:  Thomas R Webb; Amanda S Joyner; Philip M Potter
Journal:  Drug Discov Today       Date:  2012-08-03       Impact factor: 7.851
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.